Opus Genetics (IRD) Stock Chart & Stock Price History $1.13 -0.04 (-3.00%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$1.15 +0.02 (+2.12%) As of 07/18/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Opus Genetics Stock Price Performance The Opus Genetics (IRD) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 5.04%. In the past month, the stock has increased 18.93%, reflecting recent market activity. As of the latest close, Opus Genetics traded at $1.13 with a market cap of $67.42 million and volume of 195,008 shares. Receive IRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.89%1 Month Performance+18.93%3 Month Performance+52.46%Year-To-Date Performance-5.04% IRD Stock Chart for Monday, July, 21, 2025 IRD Chart by TradingView Opus Genetics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025$1.17$1.13-3.00%$1.18$1.13195,008 shs$67.42 million07/17/2025$1.12$1.17+4.02%$1.17$1.11209,847 shs$69.50 million07/16/2025$1.10$1.12+1.82%$1.13$1.08135,308 shs$66.82 million07/15/2025$1.11$1.10-0.90%$1.12$1.0993,990 shs$65.63 million07/14/2025$1.13$1.11-1.77%$1.13$1.09180,597 shs$66.22 million07/11/2025$1.12$1.13+0.89%$1.13$1.08190,833 shs$67.42 million07/10/2025$1.11$1.12+0.90%$1.15$1.10255,989 shs$66.82 million07/09/2025$1.06$1.11+4.72%$1.13$1.03557,410 shs$66.22 million07/08/2025$0.99$1.06+6.84%$1.08$1.00432,379 shs$63.24 million07/07/2025$1.00$0.99-0.79%$1.03$0.98216,074 shs$59.19 million Get the Latest News and Ratings for IRD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025$1.00$1.00$1.02$0.98186,072 shs$59.66 million07/03/2025$0.99$1.00+1.01%$1.02$0.98186,072 shs$59.66 million07/02/2025$0.94$0.99+5.33%$1.03$0.93338,031 shs$59.06 million07/01/2025$0.94$0.94-0.23%$1.00$0.90209,328 shs$56.07 million06/30/2025$0.98$0.94-3.53%$0.96$0.93318,100 shs$56.21 million06/27/2025$1.02$0.98-4.25%$1.03$0.97783,289 shs$58.26 million06/26/2025$0.97$1.02+5.13%$1.05$0.969.50 million shs$60.85 million06/25/2025$0.92$0.97+5.06%$0.98$0.92232,165 shs$57.88 million06/24/2025$0.91$0.92+1.91%$0.96$0.91114,445 shs$55.10 million06/23/2025$0.95$0.91-4.62%$0.97$0.91272,203 shs$54.06 million06/20/2025$0.93$0.95+2.16%$0.97$0.93164,097 shs$56.68 million Related Companies Inhibrx Biosciences Stock Price Chart Canopy Growth Stock Price Chart Liminatus Pharma Stock Price Chart Esperion Therapeutics Stock Price Chart biote Stock Price Chart Nanobiotix Stock Price Chart ProQR Therapeutics Stock Price Chart Acelyrin Stock Price Chart Semper Paratus Acquisition Stock Price Chart Monopar Therapeutics Stock Price Chart Receive IRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IRD) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opus Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opus Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
